Evidence map›Paper›PMID 41209303›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Application of tergitol in liver decellularization and bioink preparation based on the obtained extracellular matrix.

Paweł Mirosław, Katarzyna Kosowska, Wiktoria Serafin, Radosław Piwowar, Agnieszka Romanik-Chruścielewska, Kinga Westphal, Michał Wszoła, Marta Klak

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paweł MirosławFoundation of Research and Science Development, Warsaw, Poland.
Katarzyna KosowskaFoundation of Research and Science Development, Warsaw, Poland.
Wiktoria SerafinFoundation of Research and Science Development, Warsaw, Poland.
Radosław PiwowarFoundation of Research and Science Development, Warsaw, Poland.
Agnieszka Romanik-ChruścielewskaFoundation of Research and Science Development, Warsaw, Poland.
Kinga WestphalFoundation of Research and Science Development, Warsaw, Poland.
Michał WszołaFoundation of Research and Science Development, Warsaw, Poland.
Marta KlakFoundation of Research and Science Development, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biological materials derived from decellularized tissues are of great interest in the field of tissue engineering. Artificial organoids can be used in drug discovery or toxicological studies, potentially reducing the reliance on animal models. They also serve as valuable models for cancer and virology research. In the study, 13 slightly different detergent-enzymatic decellularization processes were performed. The end products of each process were evaluated for their DNA content, residual lipids, sulfated glycosaminoglycans (sGAG), collagen and detergent residues. To our knowledge, for the first time, Tergitol was used in liver decellularization. A method for detecting residual Tergitol content in the matrix was also developed. A significant reduction in DNA and fat content was achieved, as well as preservation of collagen. However, a marked loss of sGAGs was observed. The most promising variant involved gradient decellularization using Tergitol and ammonium hydroxide combined with pre-digestion by trypsin, which yielded the most favorable results and showed no cytotoxicity. A bioink was subsequently formulated from the decellularized matrix, which has potential applications in 3D bioprinting of artificial liver tissue.

Indexed as

bioinkdecellularizationdetergentsextracellular matrixliver

Identifiers

PMID41209303
PMCPMC12588901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.